(Q33193109)

23 July 2017

1 reference

title

New therapies for the management of keloids (English)

1 reference

23 July 2017

New Therapies for the Management of Keloids (English)

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

12 March 2024

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

12 March 2024

author name string

Brian Berman

2

1 reference

23 July 2017

Varee N. Poochareon

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14501323

12 March 2024

language of work or name

1 reference

1 September 2003

1 reference

full work available at URL

23 July 2017

http://journals.lww.com/00001665-200309000-00009

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Journal of Craniofacial Surgery

12 March 2024

published in

1 reference

23 July 2017

volume

14

1 reference

23 July 2017

issue

5

1 reference

23 July 2017

page(s)

654-657

1 reference

On the nature of hypertrophic scars and keloids: a review

23 July 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Keloidal scars: a review with a critical look at therapeutic options

12 March 2024

2

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up study

12 March 2024

4

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

In Search of the Optimal Treatment of Keloids: Report of a Series and a Review of the Literature

12 March 2024

6

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

12 March 2024

Keloids

7

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Treatment of the keloid: what is new?

12 March 2024

8

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Argon and carbon dioxide laser treatment of hypertrophic and keloid scars

12 March 2024

10

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Failure of carbon dioxide laser excision of keloids

12 March 2024

11

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

In-situ irradiation of keloid scars with Nd:YAG laser

12 March 2024

13

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Improvement of erythematous and hypertrophic scars by the 585-nm flashlamp-pumped pulsed dye laser.

12 March 2024

14

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Treatment of keloid sternotomy scars with 585 nm flashlamp-pumped pulsed-dye laser

12 March 2024

15

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Treatment of keloid scars with pulsed dye laser and intralesional steroid

12 March 2024

16

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Treatment response of keloidal and hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments

12 March 2024

17

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro

12 March 2024

18

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Intralesional interferon alpha-2b has no effect in the treatment of keloids

12 March 2024

19

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Failure of interferon-alpha 2b in the treatment of mature keloids

12 March 2024

20

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections

12 March 2024

21

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Carbon dioxide laser ablation associated with interferon alfa-2b injections reduces the recurrence of keloids

12 March 2024

22

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

A controlled trial of intralesional recombinant interferon-gamma in the treatment of keloidal scarring. Clinical and histologic findings

12 March 2024

23

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Intralesional interferon gamma treatment for keloids and hypertrophic scars

12 March 2024

24

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Review Article Imiquimod applied topically: a novel immune response modifier and new class of drug

12 March 2024

26

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids

12 March 2024

27

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Infantile hemangioma: clinical resolution with 5% imiquimod cream

12 March 2024

29

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Are keloids really "gli-loids"?: High-level expression of gli-1 oncogene in keloids

12 March 2024

31

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Pharmacologic Control of Surface Scarring in Human Beings

12 March 2024

32

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Topical putrescine (Fibrostat) in treatment of hypertrophic scars: phase II study

12 March 2024

33

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Inhibitory action of tranilast, an anti-allergic drug, on the release of cytokines and PGE2 from human monocytes-macrophages

12 March 2024

34

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Retinoic acid in the treatment of keloids

12 March 2024

36

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Pentoxifylline inhibits the proliferation of human fibroblasts derived from keloid, scleroderma and morphoea skin and their production of collagen, glycosaminoglycans and fibronectin

12 March 2024

38

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Prevention and treatment of keloids with intralesional verapamil

12 March 2024

39

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Calcium antagonists retard extracellular matrix production in connective tissue equivalent

12 March 2024

40

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Effect of tamoxifen on transforming growth factor beta1 production by keloid and fetal fibroblasts

12 March 2024

41

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

Topical tamoxifen--a potential therapeutic regime in treating excessive dermal scarring?

12 March 2024

42

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

The effects of a single dose of 5-fluorouracil on keloid scars: a clinical trial of timed wound irrigation after extralesional excision

12 March 2024

44

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

International clinical recommendations on scar management.

12 March 2024

46

1 reference

https://api.crossref.org/works/10.1097/00001665-200309000-00009

12 March 2024

Identifiers

1 reference

23 July 2017

1 reference